1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Apollomics Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML Uproleselan, Placebo - Relapsed/Refractory AML | Phase 3 | Terminated | Apollomics Inc. | 140 | 2021-11-17 | 2025-06-27 |
Sodium Chloride (1) · uproleselan (1)
China (1)